Ignite Creation Date:
2025-12-25 @ 12:10 AM
Ignite Modification Date:
2026-03-05 @ 1:15 PM
Study NCT ID:
NCT01234558
Status:
COMPLETED
Last Update Posted:
2012-09-12
First Post:
2010-11-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Single IV Dose of GLYX-13 in Patients With Treatment-Resistant Depression
Sponsor:
Naurex, Inc, an affiliate of Allergan plc
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
GLYX13-C201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None